DE60024601D1 - Dispergierbare zusammensetzungen von macroliden und verfahren zu deren herstellung - Google Patents

Dispergierbare zusammensetzungen von macroliden und verfahren zu deren herstellung

Info

Publication number
DE60024601D1
DE60024601D1 DE60024601T DE60024601T DE60024601D1 DE 60024601 D1 DE60024601 D1 DE 60024601D1 DE 60024601 T DE60024601 T DE 60024601T DE 60024601 T DE60024601 T DE 60024601T DE 60024601 D1 DE60024601 D1 DE 60024601D1
Authority
DE
Germany
Prior art keywords
agent
macrolides
production
sweetening agent
dispersible compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60024601T
Other languages
English (en)
Other versions
DE60024601T2 (de
Inventor
Noel Zakarian
Rene Gimet
Claude Laruelle
Dominique Toselli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLL Pharma SA
Original Assignee
CLL Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CLL Pharma SA filed Critical CLL Pharma SA
Application granted granted Critical
Publication of DE60024601D1 publication Critical patent/DE60024601D1/de
Publication of DE60024601T2 publication Critical patent/DE60024601T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DE60024601T 1999-03-30 2000-03-30 Dispergierbare zusammensetzungen von macroliden und verfahren zu deren herstellung Expired - Lifetime DE60024601T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9903978 1999-03-30
FR9903978A FR2793690B1 (fr) 1999-03-30 1999-03-30 Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
PCT/FR2000/000800 WO2000057886A1 (fr) 1999-03-30 2000-03-30 Composes dispersibles de macrolides et leur procede de preparation

Publications (2)

Publication Number Publication Date
DE60024601D1 true DE60024601D1 (de) 2006-01-12
DE60024601T2 DE60024601T2 (de) 2006-09-14

Family

ID=9543821

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60024601T Expired - Lifetime DE60024601T2 (de) 1999-03-30 2000-03-30 Dispergierbare zusammensetzungen von macroliden und verfahren zu deren herstellung

Country Status (13)

Country Link
US (1) US6605301B2 (de)
EP (2) EP1506780A3 (de)
AT (1) ATE311890T1 (de)
AU (1) AU3662700A (de)
BR (1) BR0009447A (de)
CA (1) CA2368880A1 (de)
DE (1) DE60024601T2 (de)
DZ (1) DZ3149A1 (de)
ES (1) ES2254158T3 (de)
FR (1) FR2793690B1 (de)
MA (1) MA25526A1 (de)
MX (1) MXPA01009845A (de)
WO (1) WO2000057886A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL151888A0 (en) * 2000-03-28 2003-04-10 Biochemie Gmbh Granulated particles with masked taste
GB0123400D0 (en) 2001-09-28 2001-11-21 Novartis Ag Organic compounds
CN1668282A (zh) 2001-12-21 2005-09-14 辉瑞产品公司 可直接压制的阿齐霉素配方
WO2003063838A1 (en) 2002-02-01 2003-08-07 Pfizer Products Inc. Dry granulated formulations of azithromycin
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound
WO2005044236A1 (en) * 2003-10-27 2005-05-19 Control Delivery Systems, Inc. Suspension delivery system for the sustained and controlled local release of pharmaceuticals
CA2614412A1 (en) * 2005-07-07 2007-01-18 Elan Pharma International, Limited Nanoparticulate clarithromycin formulations
US9198862B2 (en) * 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
CN100348190C (zh) * 2005-09-14 2007-11-14 北京正大绿洲医药科技有限公司 奥硝唑滴丸及其制备方法
EP2201939A1 (de) 2008-12-25 2010-06-30 Zentiva Kimyasal Ürünler Sanayi ve Ticaret A.S. Verfahrung zur Herstellung von beschichtetem Spiramycin und neue Formulierungen damit
CN103040778A (zh) * 2012-12-31 2013-04-17 四川科伦药业股份有限公司 一种阿奇霉素分散片及其制备方法和用途
CN104739792B (zh) * 2015-04-17 2017-11-10 四川科伦药业股份有限公司 一种罗红霉素分散片制备方法
GR1008992B (el) 2015-12-17 2017-03-23 Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης
CN108619105A (zh) * 2018-07-26 2018-10-09 江苏黄河药业股份有限公司 一种阿奇霉素分散片
CN108853039B (zh) * 2018-08-07 2021-03-09 河北君临药业有限公司 一种克拉霉素分散片及其生产工艺
CN109528672B (zh) * 2019-01-30 2021-03-16 河北君临药业有限公司 一种乙酰螺旋霉素片及其制备方法
CN110548010A (zh) * 2019-04-02 2019-12-10 海南海神同洲制药有限公司 一种罗红霉素分散片制备方法
CN111388444B (zh) * 2020-03-18 2022-05-20 北京鑫开元医药科技有限公司 一种罗红霉素颗粒及其制备方法
CN114948887A (zh) * 2022-06-17 2022-08-30 中山可可康制药有限公司 一种克拉霉素分散片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106967A (en) * 1988-05-05 1992-04-21 The Procter & Gamble Company Functional sugar substitutes with reduced calories
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
FR2696346B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Nouvelles formulations pharmaceutiques de spiramycine.
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin

Also Published As

Publication number Publication date
FR2793690B1 (fr) 2003-01-03
WO2000057886A1 (fr) 2000-10-05
EP1506780A2 (de) 2005-02-16
DE60024601T2 (de) 2006-09-14
ATE311890T1 (de) 2005-12-15
EP1165094B1 (de) 2005-12-07
ES2254158T3 (es) 2006-06-16
FR2793690A1 (fr) 2000-11-24
EP1506780A3 (de) 2005-03-02
MA25526A1 (fr) 2002-10-01
US6605301B2 (en) 2003-08-12
EP1165094A1 (de) 2002-01-02
US20020061333A1 (en) 2002-05-23
DZ3149A1 (fr) 2001-08-16
BR0009447A (pt) 2002-01-08
CA2368880A1 (fr) 2000-10-05
AU3662700A (en) 2000-10-16
MXPA01009845A (es) 2003-02-12

Similar Documents

Publication Publication Date Title
DE60024601D1 (de) Dispergierbare zusammensetzungen von macroliden und verfahren zu deren herstellung
EP1040823A3 (de) Stabile Schaumzusammensetzungen
CA2396159A1 (en) Novel substituted benzimidazole dosage forms and method of using same
HUP0001843A2 (hu) Eljárás nukleozid analógok szintézisére
IL188052A0 (en) A defecation promoting agent having adenosine a2 receptor antagonism and pharmaceutical compositions containing the same
CA2387356A1 (en) Crystal form 0 and form i of clarithromycin and uses thereof
BG104841A (en) Fizzy formulations
ES2194989T3 (es) Composicion adminstrada por via oral, que comprende una toxina de zonula occludens y un agente que tiene una actividad biologica, y su utilizacion.
ES2196331T3 (es) Derivados macrociclicos de cadena de 13 elementos de las eritromicinas a y b.
ZA964818B (en) Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds.
SK1452000A3 (en) Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
WO2002042315A3 (en) Macrolide solvates
MA26644A1 (fr) Derives de 1,7, diaza-spiro (3,5) nonane, procede de preparation et medicament les contenant
TR200002766T2 (tr) 3',3'-N-Bis-ikameli makrolit LHRH Antagonistleri
BR0109946A (pt) Derivados de eritromicina substituìda em 6-o tendo tolerância gastrointestinal
ATE289609T1 (de) Makrolid-lhrh-antagonisten
WO2000058328A3 (de) Avermectinderivate
AU2002215169A1 (en) Sanitizing composition containing chlorinated isocyanurate for in-ovo injection equipment
DE59903063D1 (de) Semi-hydrochlorid von 8-cyan-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluor-1, 4-dihydro-4- oxo-3- chinolincarbonsäure
ATE269693T1 (de) Abführmittel und verfahren zu deren herstellung
AU2712799A (en) The use of estradiol derivatives for treating side-effects during and/or after gnrha therapy
EP0937718A4 (de) Antibiotisches tkr2648 and verfahren zur herstellung desselben
BG103923A (en) Sulphate salt of hiv protease inhibitor with improved peroral absorption and biopresence
DK0874863T3 (da) 3-deoxy-3-descladinose-derivater fra erythromycin A og B
TH20307A (th) สารสูตรผสมอิมัลชันชนิดใหม่

Legal Events

Date Code Title Description
8364 No opposition during term of opposition